NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell, where it plays a central role in cellular energy metabolism. It is not a peptide but is frequently discussed alongside research peptides due to shared interest in cellular aging and metabolic research.

What Is NAD+?

NAD+ exists in two related forms — an oxidized form (NAD+) and a reduced form (NADH) — that cycle continuously as part of core metabolic reactions. It is derived biochemically from dietary precursors including tryptophan and vitamin B3 forms (niacin, nicotinamide, nicotinamide riboside, and nicotinamide mononucleotide).

NAD+’s established biological roles include:

• Redox reactions — NAD+/NADH act as electron carriers in glycolysis, the citric acid cycle, and oxidative phosphorylation, the core pathways cells use to generate ATP.
• Sirtuin activation — NAD+ is a required substrate for the sirtuin family of enzymes (SIRT1–7), which are involved in regulating gene expression, DNA repair, and metabolic signaling.
• PARP substrate — NAD+ is also consumed by PARP enzymes involved in DNA damage repair, creating biochemical competition between repair processes and sirtuin activity for available NAD+.

A well-established finding across multiple research groups is that measurable NAD+ levels decline with age in various tissues, which has driven substantial research interest in whether restoring NAD+ levels affects aspects of cellular aging.

Summary of Published Research

NAD+ metabolism is one of the most heavily studied areas in aging biology, with contributions from numerous academic labs:

• Sirtuin and longevity research: Work from researchers including Leonard Guarente (MIT) helped establish the sirtuin-NAD+ connection to lifespan regulation, initially in yeast and later extended to mammalian models.
• NAD+ precursor studies: A substantial body of research, including work associated with David Sinclair’s laboratory (Harvard), has examined NAD+ precursors such as NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) in animal models, reporting effects on measures of metabolic and mitochondrial function in mice.
• DNA repair research: Studies have examined the relationship between NAD+ availability, PARP activity, and cellular response to DNA damage.
• Human precursor trials: Unlike many compounds discussed in research contexts, NAD+ precursors (particularly NR and NMN) have been the subject of several published human clinical trials examining safety and pharmacokinetics, generally finding these precursors are tolerated and do raise measurable NAD+ levels in blood. However, trials demonstrating specific downstream health outcomes in humans remain limited, and findings are still an active area of investigation.

Direct NAD+ administration (as opposed to precursor supplementation) has a smaller and less consistent human research base, and much of what is known about direct NAD+ effects on aging biology still comes from cell and animal models.

Current Research Applications Being Studied

Active research questions involving NAD+ include:

• Cellular and mitochondrial energy metabolism across the lifespan.
• Sirtuin pathway activation and its downstream effects on gene expression.
• DNA damage response and the NAD+/PARP relationship.
• Comparative research on different NAD+ precursors and delivery methods.